Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec;10 Suppl 1(Suppl 1):25-31.
doi: 10.1111/iwj.12174.

Diabetic foot wounds: the value of negative pressure wound therapy with instillation

Luca Dalla Paola  1
Affiliations
Review

Diabetic foot wounds: the value of negative pressure wound therapy with instillation

Luca Dalla Paola. Int Wound J. 2013 Dec.

Abstract

Chronic wounds such as diabetic foot wounds are a tremendous burden to the health care system and often require a multidisciplinary approach to prevent amputations. Advanced technologies such as negative pressure wound therapy (NPWT) and bioengineered tissues have been successfully used in the treatment of these types of complex wounds. However, the introduction of NPWT with instillation (NPWTi) has provided an alternative treatment for treating complex and difficult-to-heal wounds. This article provides an overview of NPWT and the new NPWTi system and describes preliminary experience using NPWTi on patients with complicated infected diabetic foot wounds after surgical debridement and in a multidisciplinary setting.

Keywords: Diabetic foot wounds; Instillation therapy; Negative pressure wound therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Initial presentation, (B) 11 days after surgical debridement, (C) 14 days after treatment with negative pressure wound therapy with instillation (NPWTi) using polyhexamethylene biguanide (left) and 42 days after coverage with dermal substitute (right). (D) Wound was completely healed at follow‐up.
Figure 2
Figure 2
(A) Initial presentation, (B) 3 days after surgical debridement and revascularisation, (C) 15 days after treatment with negative pressure wound therapy with instillation (NPWTi) using polyhexamethylene biguanide, (D) 60 days after dermal replacement therapy and first skin graft and (E) 30 days after healing with second skin graft application.
See this image and copyright information in PMC

References

    1. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382–7. - PubMed
    1. Muller IS, de Grauw WJ, van Gerwen WH, Bartelink ML, van Den Hoogen HJ, Rutten GE. Foot ulceration and lower limb amputation in type 2 diabetic patients in Dutch primary health care. Diabetes Care 2002;25:570–4. - PubMed
    1. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The North‐West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community‐based patient cohort. Diabet Med 2002;19:377–84. - PubMed
    1. Trautner C, Haastert B, Spraul M, Giani G, Berger M. Unchanged incidence of lower‐limb amputations in a German City, 1990–1998. Diabetes Care 2001;24:855–9. - PubMed
    1. Henriksson F, Agardh CD, Berne C, Bolinder J, Lonnqvist F, Stenstrom P, Ostenson CG, Jonsson B. Direct medical costs for patients with type 2 diabetes in Sweden. J Intern Med 2000;248:387–96. - PubMed

MeSH terms